As of November 10, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Reed'S, Inc. The largest reported stake is Deng, Shufen's, at 53.5%. One filing is on record since June 5, 2026 (Schedule 13D/A, June 5, 2026).
Sell to companies like Reed'S, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Deng, Shufen · Sole voting: 0 · Shared voting: 5,995,422 · Sole dispositive: 0 · Shared dispositive: 5,995,422 · SCHEDULE 13D/A, 2026-06-05
- · Reporting person: Era Regenerative Medicine Ltd · Sole voting: 367,647 · Shared voting: 5,995,422 · Sole dispositive: 367,647 · Shared dispositive: 5,995,422 · SCHEDULE 13D/A, 2026-06-05
- · Reporting person: D&D Source of Life Holding Ltd. · Sole voting: 0 · Shared voting: 5,995,422 · Sole dispositive: 0 · Shared dispositive: 5,995,422 · SCHEDULE 13D/A, 2026-06-05
- · Reporting person: Dai, Siqi · Sole voting: 0 · Shared voting: 5,995,422 · Sole dispositive: 0 · Shared dispositive: 5,995,422 · SCHEDULE 13D/A, 2026-06-05
- · Holder: Deng, Shufen · Percent: 53.5% · SCHEDULE 13D/A
Reed'S, Inc. has 1 Schedule 13D or 13G filing on record since 2026-06-05. 1 holder's latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Deng, Shufen | 53.5% | 6,363,069 | SCHEDULE 13D/A, 2026-06-05 | 2026-05-20 |
Holding shares or following this stake? See who's behind Reed'S, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Reed'S, Inc. and the records around it.
Reed'S, Inc. elsewhere on the record
Watch Reed'S, Inc.
Get an email when Reed'S, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Reed'S, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Reed'S, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Reed'S, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Deng, Shufen | 0 | 5,995,422 | 0 | 5,995,422 | SCHEDULE 13D/A, 2026-06-05 |
| Era Regenerative Medicine Ltd | 367,647 | 5,995,422 | 367,647 | 5,995,422 | SCHEDULE 13D/A, 2026-06-05 |
| D&D Source of Life Holding Ltd. | 0 | 5,995,422 | 0 | 5,995,422 | SCHEDULE 13D/A, 2026-06-05 |
| Dai, Siqi | 0 | 5,995,422 | 0 | 5,995,422 | SCHEDULE 13D/A, 2026-06-05 |
The latest filing identifies Reed'S, Inc. by CUSIP 758338404 and gives its principal executive office as 501 Merritt 7 Corporate Park, PH, Norwalk, CT 06851 (SCHEDULE 13D/A, 2026-06-05).
Source of funds (Item 3)
Item 3 of the Schedule 13D is hereby amended and supplemented by adding the following at the end thereof: On December 30, 2024, ERM acquired 2,205,882 shares of Common Stock on a pre-Reverse Stock Split basis (equivalent to 367,647 shares after giving effect to the Reverse Stock Split) directly from the Issuer in a private placement of securities by the Issuer to investors, as disclosed in the Issuer's Current Report on Form 8-K relating to such private placement. The source of funds for such acquisition was the working capital of ERM.Deng, Shufen, SCHEDULE 13D/A, 2026-06-05
Purpose of Transaction (Item 4)
Deng, Shufen
Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following at the end thereof: Deng Shufen was appointed as an authorized signatory of D&D on May 20, 2026. By virtue of such appointment and the other arrangements described herein, the Reporting Persons may be deemed to have become a group within the meaning of Rule 13d-5(b)(1) under the Act on that date. Dai Siqi has, since the date ERM acquired its interest in D&D, been the sole shareholder and sole director of ERM and an authorized signatory of D&D. By virtue of such positions, Dai Siqi has shared voting and dispositive power with respect to the securities of the Issuer beneficially owned by ERM and D&D since such date. In connection with the formation of a group with the other Reporting Persons on May 20, 2026 and on review of the prior Schedule 13D filings, the Reporting Persons have determined to identify Dai Siqi as a Reporting Person in this Amendment going forward. ERM acquired the shares purchased in the December 2024 private placement, D&D acquired the shares purchased from the Whitebox Sellers pursuant to the Whitebox PSA, and D&D acquired the units purchased in the Issuer's December 2025 underwritten public offering, in each case for investment purposes and in connection with the transactions relating to the amendment and restructuring of the Issuer's senior secured financing arrangements and the Issuer's capital-raising and NYSE American listing. As a result of these acquisitions, …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-06-05; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-06-05 | Deng, Shufen | 53.5% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Reed'S, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.